Brief: Cue Biopharma, Inc. Q2 collaboration revenue USD 1.382 million
09/08/2023 21:13
Aug 9 (Reuters) - Cue Biopharma, Inc. Q2 basic EPS USD -0.29. * Q2 collaboration revenue USD 1.382 million * Q2 operating expenses USD 14.899 million * Q2 net income USD -13.185 million * Q2 income from operations USD -13.517 million
Recent news on Cue Biopharma
See all newsU.S. STOCKS ON THE MOVE-Insmed, Marvell, Meta
US STOCKS ON THE MOVE-Meta, Marvell Technology, Insmed
U.S. STOCKS ON THE MOVE-Accenture, Arhaus, Alkermes
Cue Biopharma surges after positive results from mid-stage study for CUE-221
Brief: Cue Biopharma Announces Positive Topline Results From Cue-221 Phase 2 Study In Chronic Spontaneous Urticaria